Attached files

file filename
10-K - FORM 10-K - Enochian Biosciences Ince2119_10-k.htm
EX-32.1 - EXHIBIT 32.1 - Enochian Biosciences Ince2119_32-1.htm
EX-31.2 - EXHIBIT 31.2 - Enochian Biosciences Ince2119_31-2.htm
EX-31.1 - EXHIBIT 31.1 - Enochian Biosciences Ince2119_31-1.htm
EX-23.1 - EXHIBIT 23.1 - Enochian Biosciences Ince2119_23-1.htm
EX-14.1 - EXHIBIT 14.1 - Enochian Biosciences Ince2119_14-1.htm
EX-4.1 - EXHIBIT 4.1 - Enochian Biosciences Ince2119_4-1.htm

Exhibit 32.2

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Enochian Biosciences Inc. (the “Company”) on Form 10-K for the year ending June 30, 2020 as filed with the Securities and Exchange Commission (the “Report”), the undersigned, Luisa Puche, as Chief Financial Officer (Principal Financial Officer) of the Company, hereby certifies as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge: 

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
   
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

Date: September 23, 2020  
   
/s/ Luisa Puche  
Luisa Puche  
Chief Financial Officer
(Principal Financial and Accounting Officer)